Evidence map›Paper›PMID 40111714›Full record

ArticleMolecular imaging and biology2025

Development of a CT-less SPECT Acquisition Protocol for Kidney Dosimetry in

Christian Happel, Larissa Völler, Benjamin Bockisch, Daniel Groener, Britta Leonhäuser, Frank Grünwald, Amir Sabet

Abstract read
In one paragraph

Article in Molecular imaging and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christian HappelDepartment of Nuclear Medicine, Clinic for Radiology and Nuclear Medicine, Goethe University Frankfurt, University Hospital Frankfurt, Theodor Stern Kai 7, D-60590, Frankfurt, Germany. Christian.Happel@ukffm.de.ORCID http://orcid.org/0000-0001-6786-1452
Larissa VöllerDepartment of Nuclear Medicine, Clinic for Radiology and Nuclear Medicine, Goethe University Frankfurt, University Hospital Frankfurt, Theodor Stern Kai 7, D-60590, Frankfurt, Germany.
Benjamin BockischDepartment of Nuclear Medicine, Clinic for Radiology and Nuclear Medicine, Goethe University Frankfurt, University Hospital Frankfurt, Theodor Stern Kai 7, D-60590, Frankfurt, Germany.
Daniel GroenerDepartment of Nuclear Medicine, Clinic for Radiology and Nuclear Medicine, Goethe University Frankfurt, University Hospital Frankfurt, Theodor Stern Kai 7, D-60590, Frankfurt, Germany.
Britta LeonhäuserDepartment of Nuclear Medicine, Clinic for Radiology and Nuclear Medicine, Goethe University Frankfurt, University Hospital Frankfurt, Theodor Stern Kai 7, D-60590, Frankfurt, Germany.
Frank GrünwaldDepartment of Nuclear Medicine, Clinic for Radiology and Nuclear Medicine, Goethe University Frankfurt, University Hospital Frankfurt, Theodor Stern Kai 7, D-60590, Frankfurt, Germany.
Amir SabetDepartment of Nuclear Medicine, Clinic for Radiology and Nuclear Medicine, Goethe University Frankfurt, University Hospital Frankfurt, Theodor Stern Kai 7, D-60590, Frankfurt, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTargeted radioligand therapy of metastatic castration-resistant prostate cancer (mCRPC) with PROCEDURES: A dedicated torso phantom with kidneys filled with a solution of

resultsVolumes of interest of the kidneys were drawn in the three sequential SPECT-images to calculate intra-renal effective half-life. Absolute quantification of activity in the kidneys was accomplished obtaining a patient individual sensitivity based on the individual attenuation in the patient. Kidney dose was then calculated applying a bi-exponential time activity curve in Microsoft EXCEL. Mean kidney dose per administered activity was 0.54 (± 0.26) Gy/GBq.

conclusionsWith the presented procedure a reliable kidney dosimetry is possible without the use of SPECT/CT. Facilities without SPECT/CT are therefore able to perform an adequate kidney dosimetry without additional radiation exposure for the patient.

Indexed as

DipeptidesHeterocyclic Compounds, 1-RingKidneyLutetiumRadioisotopesRadiometrySingle Photon Emission Computed Tomography Computed TomographyTomography, Emission-Computed, Single-PhotonAgedHumansMaleMiddle AgedPhantoms, ImagingProstate-Specific AntigenProstatic Neoplasms, Castration-ResistantRetrospective StudiesDipeptidesHeterocyclic Compounds, 1-RingLutetiumLutetium-177PluvictoProstate-Specific AntigenPSMA-617Radioisotopes177Lu-PSMAKidney dosimetryRadioligand therapy

Identifiers

PMID40111714
PMCPMC12162791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.